ArticleHemaSphere2026

Blinatumomab in de novo AYA ALL-Results of the Australasian Leukaemia and Lymphoma Group ALL09 "SUBLIME" study.

Matthew Greenwood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.